United Airlines Holdings, Inc. - Common Stock (UAL)

CUSIP: 910047109

Q2 2019 13F Holders as of 30 Jun 2019

Security type / class
Equity / Common Stock
Total 13F shares
253,320,638
Total 13F value
$22,158,166,405
Holder snapshot 6 visible 7 signals
Share change
-7,441,823
Put/Call ratio
248%
SEC-reported price per share
$87.55
Number of holders
564
Value change
-$632,718,573
Number of buys
213
Open additional details 1 more signal available
Number of sells
306
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
321,928,750

Security key

910047109

Report period

Q2 2019

Institutions

564

Top holders

10

UAL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2019 Previous quarter: Q1 2019 United Airlines Holdings, Inc. SEC filings United Airlines Holdings, Inc. company facts United Airlines Holdings, Inc. 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of UAL - United Airlines Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
PRIMECAP MANAGEMENT CO/CA/
Comparable rows
15/15
Latest evidence
31 Mar 2019
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership Top 5
PRIMECAP MANAGEMENT CO/CA/ 12%
BERKSHIRE HATHAWAY INC 6.8%
VANGUARD GROUP INC 6.5%
PAR CAPITAL MANAGEMENT INC 4.9%
BlackRock Finance, Inc. 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
12%
$3,048,045,000
38,205,624 shares
 — 31 Mar 2019
BERKSHIRE HATHAWAY INC
13F
Company
13F
6.8%
$1,750,265,000
21,938,642 shares
 — 31 Mar 2019
VANGUARD GROUP INC
13F
Company
13F
6.5%
$1,668,962,000
20,919,553 shares
 — 31 Mar 2019
PAR CAPITAL MANAGEMENT INC
13F
Company
13F
4.9%
$1,246,096,000
15,619,152 shares
 — 31 Mar 2019
BlackRock Finance, Inc.
13F
Company
13F
4.3%
$1,114,312,000
13,967,270 shares
 — 31 Mar 2019
Altimeter Capital Management, LP
13F
Company
13F
3.6%
$927,784,000
11,629,283 shares
 — 31 Mar 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
564
Shares
253,320,638
Rows available
564
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
592
Q2 2019 holders
564
Holder diff
-28
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 value Q2 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .